Shanghai Bio-heart Biological Technology Co., Ltd.

HK$0.97As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2185Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (49.57%)
Div yield —
ROE (12.16%)
Medical Devices
Beta (5Y) 0.18
PE TTM —
TSR TTM (88.28%)
Mkt cap HK$237.3M
ROIC (8.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.933
(4.32%)
(97.91%)
Sell 9|2|10|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.02
0.02
(0.02%)
7.44%
15.25%
25.21%
Revenue¥M
15.01
14.66
14.77
15.08
10.57%
3.14%
3.32%
5.94%
Peers (US$30.43M)
Cap (US$)
PE
45.53M
—
30.48M
60.74x
Capital
TTM
5Y
10Y
Leveragex
1.869
0.356
0.241
EBIT/Intx
0.864
0.837
0.726
Own earn%
(103.17)
(123.65)
(115.38)
Sh yield%
19.30
37.94
40.65
Owners
Insiders/Inst%
11.80
61.88
Short interest%
5.44
SBC / revenue%
3.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
7